Zhejiang Int'L Group Co Ltd (000411) fair value: what the stock is really worth
As of Sep 22, 2026: fair value of Zhejiang Int'L Group Co Ltd ¥19.52, price ¥9.98, upside +95.6%, quality 39 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? No
- Add to watchlist
Zhejiang Int'L Group Co Ltd
000411 · SHECheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ¥7.64 – ¥14.24 · fair‑value band ¥14.64 – ¥24.40 · the ¥9.98 price screens below the ¥19.52 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Every Wednesday you see whether Zhejiang Int'L Group Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.
Stock analysis
Zhejiang Int'L Group Co Ltd (000411) currently trades at ¥9.98, while our model-based Fair Value estimate is ¥19.52, implying the stock looks roughly 48.9% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥41.23 per share, and 21 of the 23 models we run sit above the ¥9.98 price.
Bear case: the Asset-Based group reads lowest at ¥6.05, and 2 of the 23 models stay below the price. Evidence for this calculation is high.
Scenario range: ¥14.64 (bear) to ¥24.40 (bull), the price of ¥9.98 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Zhejiang Int'L Group Co Ltd reported revenue of 33.7B CNY in FY2025 versus 26.7B CNY in FY2021, a compound +5.9%/yr. Reported net income was 501M CNY in FY2025, compounding +31.5%/yr from FY2021.
Key figures
Market cap 5.4B CNY (≈ $806M) · P/E ratio 11.2 · P/S ratio 0.17 · EPS (TTM) ¥0.8900 · Dividend yield 3.5% · Net margin 1.5% · Return on equity 10.3% · Return on assets (EBIT) 5.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).
What moves the price
The share trades about 27% below its 52-week high and 15% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at 96%, 000411 screens cheaper than that median.
Fair Value models
All 23 models by family
Notify me when 000411 reaches fair value
Put 000411 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Of which business quality 40 · Market factors (momentum, volatility) 45
Revenue & earnings trend
Growth Forecast
Watch 000411, get fair value alerts →
Compare Zhejiang Int'L Group Co Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - General · 73 stocks
Valuation Multiplesvs Drug Manufacturers - General median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - General stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Eli Lilly and Company LLY | $1,170 | $791.40 | −32% |
| Johnson & Johnson, JNJ | $269.19 | $169.04 | −37% |
| AbbVie Inc ABBV | $265.21 | $259.66 | −2% |
| Roche Holding RO | CHF 375.20 | CHF 329.11 | −12% |
| Merck & Co MRK | $150.91 | $129.12 | −14% |
| Novartis AG NOVN | CHF 116.46 | CHF 119.10 | +2% |
| Amgen Inc AMGN | $410.24 | $451.26 | +10% |
| Gilead Sciences, Inc GILD | $152.67 | $198.51 | +30% |
| Pfizer Inc PFE | $27.93 | $24.87 | −11% |
| Bristol-Myers Squibb Company BMY | $62.25 | $75.98 | +22% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Zhejiang Int'L Group Co Ltd (000411) overvalued or undervalued?
What is the fair value of 000411?
What is the quality score of 000411?
What is the price target for Zhejiang Int'L Group Co Ltd (000411)?
What is the Zhejiang Int'L Group Co Ltd stock forecast for 2026?
What is the revenue of Zhejiang Int'L Group Co Ltd (000411)?
Does Zhejiang Int'L Group Co Ltd pay a dividend?
What growth is priced into Zhejiang Int'L Group Co Ltd (000411)?
What discount rate (WACC) does the fair value of 000411 use?
What is a reverse DCF?
How much growth has Zhejiang Int'L Group Co Ltd (000411) delivered so far?
How fast is the sector of Zhejiang Int'L Group Co Ltd (000411) growing?
What is the free cash flow yield of Zhejiang Int'L Group Co Ltd (000411)?
What is the intrinsic value of Zhejiang Int'L Group Co Ltd (000411)?
Is Zhejiang Int'L Group Co Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 000411?
How much is Zhejiang Int'L Group Co Ltd worth?
What do the bullish and bearish scenarios say about 000411?
What is the P/E ratio of 000411?
How solid is the balance sheet of Zhejiang Int'L Group Co Ltd (000411)?
How far is 000411 from its 52-week high?
Which stocks are comparable to Zhejiang Int'L Group Co Ltd?
Is Zhejiang Int'L Group Co Ltd stock attractive at the current price?
How is the fair value of 000411 calculated?
Is it still worth investing in stocks now?
What is the share price of Zhejiang Int'L Group Co Ltd (000411)?
What should I pay attention to with Zhejiang Int'L Group Co Ltd right now?
Where does the earnings growth of Zhejiang Int'L Group Co Ltd (000411) come from?
Key figures of Zhejiang Int'L Group Co Ltd
How large is the market capitalisation of Zhejiang Int'L Group Co Ltd (000411)?
What is the P/S ratio of Zhejiang Int'L Group Co Ltd (000411)?
What are the earnings per share of Zhejiang Int'L Group Co Ltd (000411)?
What is the dividend yield of Zhejiang Int'L Group Co Ltd (000411)?
What is the net margin of Zhejiang Int'L Group Co Ltd (000411)?
What is the return on equity of Zhejiang Int'L Group Co Ltd (000411)?
What is the EBIT return on assets of Zhejiang Int'L Group Co Ltd (000411)?
What is the operating margin of Zhejiang Int'L Group Co Ltd (000411)?
How fast is revenue growing at Zhejiang Int'L Group Co Ltd (000411)?
How fast are earnings growing at Zhejiang Int'L Group Co Ltd (000411)?
How much net debt does Zhejiang Int'L Group Co Ltd (000411) carry?
Watch Zhejiang Int'L Group Co Ltd in the live analysis
One click puts Zhejiang Int'L Group Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.